Planning Committee
Peter Bulova, MD, Professor of Medicine, Division of General Internal Medicine, University of Pittsburgh Medical Center
Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center; Faculty, Lutheran General Hospital Family Medicine Residency
Laura Cifra-Bean, MD, Down Syndrome Association of Northeast Ohio
Shannon Frizzell, MS, RD, LDN, Clinical Dietitian, Adult Down Syndrome Center of Western Pennsylvania
Laura Krohn, Advocate Medical Group Adult Down Syndrome Center
Lina Patel, PsyD, Associate Professor of Psychiatry, University of Colorado School of Medicine, Aurora, Colorado
Emilie Perkins, Director of Client and Conference Services, Raybourn Group International
Moya Peterson, PhD, APRN, FNP-BC, Adults with Down Syndrome Specialty Clinic, Department of Family Medicine and Community Health, University of Kansas Medical Center
Mary Pipan, MD, University of Pennsylvania School of Medicine
Karin Roseman, LSW, Jefferson Continuing Care Program
Maria Stanley, MD, FAAP, Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic
Pat Zidek, RN, Advocate Aurora Health, Adult Down Syndrome Clinic
Program Presenters
- Shannon Frizzell, MS, RD, LDN, Clinical Dietitian, Adult Down Syndrome Center of Western Pennsylvania
- Lauren Ptomey, PhD, RD, LD, Associate Professor, University of Kansas School of Medicine
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
NAME | ROLE(S) | FINANCIAL RELATIONSHIP DISCLOSURE(S) | DISCUSSION OF UNLABELED/UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION? |
Shannon Frizzell, MS, RD, LDN | Speaker | No relevant relationships with ineligible companies to disclose | No |
Cathy Means | Planner | No relevant relationships with ineligible companies to disclose | No |
Lauren Ptomey, PhD, RD, LD | Speaker | No relevant relationships with ineligible companies to disclose | No |